The direct offering and private placement of shares by SELLAS Life Sciences Group will likely lead to dilution of existing shares, which could negatively impact the stock price in the short term. However, this move is also a way for the company to raise necessary capital, which could be beneficial for its long-term growth and development. The negative short-term impact is based on the common market reaction to share dilution.